Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. - Wikidata - wikimedia - TriplyDB

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice.

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice.

http://www.wikidata.org/entity/Q36916955

about

MicroRNA-regulated viral vectors for gene therapy AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer The potential of adeno-associated viral vectors for gene delivery to muscle tissue.Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina.Pompe disease gene therapy.MicroRNAs in cardiovascular disease.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice Input-specific regulation of hippocampal circuit maturation by non-muscle myosin IIB.Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.Gene therapy for the treatment of heart failure: promise postponed Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression.Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.Adeno-associated virus-mediated gene therapy for metabolic myopathy.Modification of cardiovascular ion channels by gene therapy.Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus.Recombinant adeno-associated virus serotype 9 in a mouse model of atherosclerosis: Determination of the optimal expression time in vivo.Targeted gene therapy for the treatment of heart failure.Cardiac applications of optogenetics.Current Methods in Cardiac Gene Therapy: Overview.Copackaging of multiple adeno-associated viral vectors in a single production step.A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform.Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy Targeting transgene to the heart and liver with AAV9 by different promoters.Successful transfection of genes using AAV-2/9 vector in swine coronary and peripheral arteries.microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice.Restoring heart function and electrical integrity: closing the circuit.Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth.

P2860

Q26745822-32702DFD-1290-4324-B054-B48D76F4ADE5 Q28297096-97CD6962-CF3A-4CDF-BB05-38F11EF60265 Q30515514-4140FB41-2688-4425-A3EC-32F7748D5BBB Q33902499-8BE662FC-5FA0-4333-B926-8E504402530F Q34205620-6F10AAB5-24E4-4D6D-A287-1175A8A1C5D3 Q34684652-7DC00FF5-76A1-41C0-AC90-8AA194E072D2 Q34982843-6DA98BB5-BEB5-471C-B7F7-4D659CD3866F Q34988737-8C1D9EDF-A93D-4FBD-B922-AE89C68DC98A Q35238264-01BAF036-BA45-4B1D-89F5-A196F31394B3 Q35651103-14EB1CA2-0468-4294-94AF-A48A86D8E8B0 Q35832885-E83C14CA-FA3A-4D67-A22A-1502206CE5C1 Q36164927-926B14C9-D2AC-404E-AB17-43EEEBD0D749 Q36266510-99EC12A2-3513-4C36-BD70-5B451144D6D3 Q36883822-4D7180AB-F7F3-4654-9335-18027766413F Q36953151-D9F42F14-0684-4D83-86E0-3CA57092982C Q37122371-070EE44C-9F1F-4B7D-8AE9-942B820C575B Q37181416-96B2A3A1-ED0A-4368-A892-DB10223CA038 Q37272261-43121CCA-E12B-4BC0-A516-1C49C94C9468 Q37578556-B528BDBC-8958-4405-9A50-4012A5641AD4 Q37615161-E5526EE1-C1A2-4728-9765-40170FCE698B Q37684597-3F500933-25B1-4A5E-9E44-09619D208A4B Q37720225-8012747C-DF44-48ED-83FC-038C78CFD785 Q37878086-B61AF93C-9E63-40E3-ABAA-0E1CCD864DF3 Q38230888-48A25A02-3AA8-4BC5-A702-C2E2FC7A7612 Q38788217-63F958A5-19F5-4338-925A-CEB8199C4998 Q38964154-233F7A90-3147-4706-9F5A-E8DACCA006C1 Q39737661-A7AB9760-6F46-4699-B822-A14996E9F93A Q40516718-E92968B1-C1F2-4E2B-B696-B95FA2B968AF Q40738027-398F551D-13A4-4114-80D7-9265B80D578B Q41822591-3F0EBC7F-C877-4724-98C5-C32D6810EB62 Q43703662-43FC3F28-66CC-4093-BB48-08A2A5182783 Q46389336-1D8E33D6-010E-460D-9644-8004ABAE8C72 Q52687520-ABE766EC-CA3A-45C1-A611-20FA5CE83189 Q54262478-B2AD1E17-8B73-4477-B231-3FE37770E137

P2860

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice.

http://www.wikidata.org/entity/Q36916955

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Tissue specific promoters impr ...... ene delivery in neonatal mice.

@en

type

label

Tissue specific promoters impr ...... ene delivery in neonatal mice.

@en

prefLabel

Tissue specific promoters impr ...... ene delivery in neonatal mice.

@en

P1433

Q36916955-E56897C3-6F25-448F-A723-CF95520E78B2

P1476

Q36916955-5E83FC91-46EE-4B8F-9FE6-49E85851F77A

P2093

Q36916955-4EA4ADD3-951F-4035-AD7E-27CEFAFC4BAA

Q36916955-A5D83400-DAB9-4185-8918-609127D0C87F

Q36916955-C478C6F5-3C69-41AF-8448-4C258B22242E

Q36916955-F7D7AE98-84CC-4BF1-BE88-79FDB5F279F3

P2860

Q36916955-13BDD2B2-E84A-46F0-89FA-2075B6A55156

Q36916955-145D3899-A00F-4101-A278-2315956AE114

Q36916955-18D8ED1C-3327-4D6E-B21F-D44CD86C3D3C

Q36916955-2057A8CE-76F8-4D5C-8A54-A058F2277075

Q36916955-2EAE2561-D64D-4721-B6A6-084677C80D38

Q36916955-36D75BDF-5A82-445D-85B5-D78FDD42B325

Q36916955-4A06364C-6CA9-4681-851F-45F32163446E

Q36916955-646011FD-28ED-40C5-BC98-1687EE07EC69

Q36916955-656F86B8-2795-4802-ABA7-A4FB42437515

Q36916955-6FDD3DF8-D734-4240-89D2-019512E6A00D

P2888

Q36916955-8F03D77F-E75A-4135-BE52-D711DC10D321

P304

Q36916955-C84CC5FF-63C6-4B57-BC14-4CF62B80C124

P31

Q36916955-4209437D-78D2-49F1-9464-EF46CD419D77

P356

Q36916955-416E1D22-E82C-4553-8BC3-51A07884CD16

P478

Q36916955-BB825764-40E7-416B-9802-7DD3BC8E4289

P50

Q36916955-98A4C6EF-52E1-4600-89D6-D5BE7A720E46

P577

Q36916955-F4E0F292-2D87-4C3D-88DC-3C36E9924693

P5875

Q36916955-0F6A030D-56A4-495D-9103-1543C0010888

P6179

Q36916955-6C8202A7-A8CA-4E90-ABB3-FF511CB2E41C

P698

Q36916955-9DACE9A7-7022-4DFC-8FA2-839A91BDC315

P932

Q36916955-13F898E9-E583-467F-9A8E-34B843653BF6

P356

P1433

Genetic Vaccines and Therapy

P1476

Tissue specific promoters impr ...... gene delivery in neonatal mice

@en

P2093

Barry J Byrne

http://www.w3.org/2001/XMLSchema#string

Cathryn S Mah

http://www.w3.org/2001/XMLSchema#string

Christina A Pacak

http://www.w3.org/2001/XMLSchema#string

Yoshihisa Sakai

http://www.w3.org/2001/XMLSchema#string

P2860

Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.

Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.

Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector.

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells.

Novel cell lines promote the discovery of genes involved in early heart development.

Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction.

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-0556-6-13

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Bijoy D Thattaliyath

P577

2008-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23276993

http://www.w3.org/2001/XMLSchema#string

P6179

1004391494

http://www.w3.org/2001/XMLSchema#string

P698

18811960

http://www.w3.org/2001/XMLSchema#string

P932

2557000

http://www.w3.org/2001/XMLSchema#string